| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Revenue | $12.66B | -12.6% |
| Cost of Revenue | $10.35B | -14.6% |
| R&D Expense | $82.0M | +1.2% |
| SG&A Expense | $886.0M | +4.2% |
| Operating Income | $1.08B | -13.1% |
| Pre-tax Income | $742.0M | -20.6% |
| Income Tax | $133.0M | -20.8% |
| Net Income | $609.0M | -20.5% |
| EPS (Basic) | $5.07 | -13.6% |
| EPS (Diluted) | $4.95 | -14.2% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.20B | -14.7% |
| Accounts Receivable | $1.57B | -11.8% |
| Inventory | $1.56B | -13.6% |
| Current Assets | $4.53B | -12.2% |
| Total Assets | $16.59B | -2.2% |
| Current Liabilities | $2.71B | -4.6% |
| Long-term Debt | $8.97B | -2.9% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.61B | +3.3% |
| Capital Expenditures | $689.0M | +0.3% |
| Investing Cash Flow | -$776.0M | -60.7% |
| Financing Cash Flow | -$1.07B | -52.1% |
| Free Cash Flow | $926.0M | +5.7% |
| Total Liabilities |
| $13.37B |
| -2.8% |
| Stockholders' Equity | $3.22B | +0.6% |